These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 23301835

  • 1. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.
    Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, Desmond PV, Bowden DS, Thompson AJ.
    J Gastroenterol Hepatol; 2013 May; 28(5):861-6. PubMed ID: 23301835
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.
    Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y, Zeuzem S, Buster EH, Uitterlinden AG, Hansen BE, Chan HL, Janssen HL.
    Gastroenterology; 2012 Mar; 142(3):513-520.e1. PubMed ID: 22108195
    [Abstract] [Full Text] [Related]

  • 3. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
    Wei L, Wedemeyer H, Liaw YF, Chan HL, Piratvisuth T, Marcellin P, Jia J, Tan D, Chow WC, Brunetto MR, Diago M, Gurel S, Morozov V, He H, Zhu Y, Wat C, Surujbally B, Thompson AJ.
    PLoS One; 2018 Mar; 13(7):e0199198. PubMed ID: 30016335
    [Abstract] [Full Text] [Related]

  • 4. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B.
    Wu H, Zhao G, Qian F, Liu K, Xie J, Zhou H, Xu J, Xu Y, Han Y, Xie Q, Wang H.
    Liver Int; 2015 Feb; 35(2):473-81. PubMed ID: 24517415
    [Abstract] [Full Text] [Related]

  • 5. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.
    Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH.
    Antivir Ther; 2011 Feb; 16(5):629-37. PubMed ID: 21817184
    [Abstract] [Full Text] [Related]

  • 6. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML, Peng CY, Dai CY, Lai HC, Huang CF, Hsieh MY, Huang JF, Chen SC, Lin ZY, Yu ML, Chuang WL.
    PLoS One; 2015 Feb; 10(4):e0122259. PubMed ID: 25835020
    [Abstract] [Full Text] [Related]

  • 7. Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon.
    Boglione L, Cusato J, Allegra S, Esposito I, Patti F, Cariti G, Di Perri G, D'Avolio A.
    Antiviral Res; 2014 Feb; 102():35-43. PubMed ID: 24316030
    [Abstract] [Full Text] [Related]

  • 8. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.
    Lampertico P, Viganò M, Cheroni C, Facchetti F, Invernizzi F, Valveri V, Soffredini R, Abrignani S, De Francesco R, Colombo M.
    Hepatology; 2013 Mar; 57(3):890-6. PubMed ID: 22473858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ, Rijckborst V, Cakaloglu Y, Simon K, Heathcote EJ, Tabak F, Mach T, Boucher CA, Hansen BE, Zeuzem S, Janssen HL.
    Antivir Ther; 2012 Mar; 17(1):9-17. PubMed ID: 22267464
    [Abstract] [Full Text] [Related]

  • 11. Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus.
    Domagalski K, Pawłowska M, Zaleśna A, Pilarczyk M, Rajewski P, Halota W, Tretyn A.
    World J Gastroenterol; 2016 Nov 07; 22(41):9186-9195. PubMed ID: 27895405
    [Abstract] [Full Text] [Related]

  • 12. Single Nucleotide Polymorphism of Interferon Lambda-4 Gene is not Associated with Treatment Response to Pegylated Interferon in Thai Patients with Chronic Hepatitis B.
    Limothai U, Wasitthankasem R, Poovorawan Y, Tangkijvanich P.
    Asian Pac J Cancer Prev; 2015 Nov 07; 16(13):5515-9. PubMed ID: 26225703
    [Abstract] [Full Text] [Related]

  • 13. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J, Jones J, Takeda A, Davidson P, Price A.
    Health Technol Assess; 2006 Aug 07; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [Abstract] [Full Text] [Related]

  • 14. Peginterferon α in the treatment of chronic hepatitis B.
    Tseng TC, Kao JH, Chen DS.
    Expert Opin Biol Ther; 2014 Jul 07; 14(7):995-1006. PubMed ID: 24738850
    [Abstract] [Full Text] [Related]

  • 15. Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
    Huang Z, Deng H, Zhao Q, Zheng Y, Peng L, Lin C, Zhao Z, Gao Z.
    Eur J Gastroenterol Hepatol; 2013 Oct 07; 25(10):1165-9. PubMed ID: 23571612
    [Abstract] [Full Text] [Related]

  • 16. Genotype F of hepatitis B: response to interferon.
    Venegas M, Poniachik J, Fuster F, Hurtado C, Villanueva RA, Brahm J.
    Antivir Ther; 2015 Oct 07; 20(4):453-6. PubMed ID: 25321866
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study.
    Lee IC, Huang YH, Su CW, Wang YJ, Huo TI, Lee KC, Lin HC.
    PLoS One; 2013 Oct 07; 8(10):e76798. PubMed ID: 24124595
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
    Zhang Q, Lapalus M, Asselah T, Laouénan C, Moucari R, Martinot-Peignoux M, Bieche I, Estrabaud E, De Muynck S, Boyer N, Bedossa P, Vidaud M, Marcellin P, Lada O.
    J Viral Hepat; 2014 Jul 07; 21(7):525-32. PubMed ID: 24118626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.